BenchSci vs PostEra
BenchSciDrug Discovery Platforms
CustomPublished price
PostEraDrug Discovery Platforms
CustomPublished price
BenchSci Drug Discovery Platforms AI for antibody research. | PostEra Drug Discovery Platforms Medicinal Chemistry Powered by Machine Learning | |
|---|---|---|
| Overview | ||
| Category | Drug Discovery Platforms | Drug Discovery Platforms |
| What it is | BenchSci provides an AI platform that helps scientists find published antibody data to improve experiment design and reduce reagent waste. | AI-powered medicinal chemistry platform that accelerates drug design through synthesis-aware generative chemistry and retrosynthesis. |
| Pricing | ||
| Published price | Custom BenchSci's ASCEND platform is enterprise-only, quoted per organization by user count and depth of internal data integration (ELN/LIMS); no public rate card. Limited free access is… | Custom No public pricing; partnership/collaboration-based. PostEra engages pharma partners under drug-discovery deals (with Pfizer, Amgen and others) rather than a self-serve subscriptio… |
| Pricing model | Custom quote | Custom quote |
| Free options | Free plan · Free trial | No free plan · No free trial |
| Deal on Cubbie | None right now | None right now |
| Company | ||
| Founded | 2015 | 2019 |
| Team size | 201-500 employees | 51-200 employees |
| Headquarters | Toronto, Canada | Boston, MA |
| Featured clients | Pfizer, Novartis, Roche | Not available |